Recombinant Delftia acidovorans Acyl Carrier Protein (acpP) is a type II PKS-associated carrier protein critical for shuttling intermediates during polyketide biosynthesis. Unlike native ACPs, the recombinant variant is engineered for compatibility with the surfactin-producing phosphopantetheinyl transferase (Sfp), enabling efficient post-translational modification. This allows in vitro reconstitution of non-actinomycete PKS systems, which are otherwise challenging to study .
Native D. acidovorans ACP (dacACP) exhibits low Sfp compatibility due to residues interfering with Ppant arm transfer. Key engineering steps include:
T43L Mutation: Replacing threonine with leucine at position 43 mimics the hydrophobic environment of Sfp-compatible carrier proteins .
Secondary Mutations: Residues G31 and V38 further stabilize interactions with Sfp’s hydrophobic binding pocket .
| ACP Variant | Sfp Activation Efficiency |
|---|---|
| Wild-Type dacACP | <5% |
| Engineered (T43L) | >95% |
| Data from in vitro activation assays . |
Recombinant dacACP has been heterologously expressed in E. coli and functionally paired with ketosynthase-chain length factor (KS-CLF) complexes. Key findings:
Holo-ACP Formation: Sfp efficiently converts apo-dacACP to holo-dacACP, confirmed by MALDI-TOF mass spectrometry .
Polyketide Synthesis: Activated dacACP supports the production of aromatic polyketides when combined with KS-CLF and malonyl-CoA extender units .
The engineered ACP has enabled advances in:
Delftibactin Production: D. acidovorans uses ACPs in non-ribosomal peptide synthetase (NRPS) pathways to produce delftibactin, a gold-binding metabolite. Recombinant ACPs facilitate heterologous expression in E. coli .
Substrate Flexibility: The minimal PKS system incorporating dacACP accepts diverse priming molecules (e.g., acetyl-CoA, propionyl-CoA), expanding product diversity .
Product Specificity: Unpredictable product profiles in in vitro systems require further mechanistic studies .
Broader Compatibility: Extending engineering strategies to ACPs from other proteobacteria and firmicutes .
KEGG: dac:Daci_5269
STRING: 398578.Daci_5269
Delftia acidovorans is an aerobic, non-fermenting, Gram-negative bacillus belonging to the family Comamonadaceae within the Burkholderiales order of Betaproteobacteria . Although typically considered an environmental organism found in soil, water systems, and plant rhizospheres, it occasionally causes opportunistic infections in both immunocompromised and immunocompetent patients .
The Acyl carrier protein (acpP) in D. acidovorans, like other bacterial acpP proteins, likely plays a crucial role in fatty acid biosynthesis, serving as a shuttle that carries growing fatty acid chains between enzymatic domains. This protein would be particularly interesting for researchers studying bacterial metabolism, biotransformation capabilities, and potential applications in biodegradation.
D. acidovorans has gained scientific interest due to its remarkable metabolic versatility, including its ability to:
Produce gold nanoparticles from gold ions via delftibactin production
Degrade various environmental pollutants, including dichlorprop through the activity of enantiospecific α-ketoglutarate dependent dioxygenases
Form biofilms with other bacteria like Cupriavidis metallidurans on gold nuggets
While the specific structural details of D. acidovorans acpP are not directly presented in the provided sources, we can infer structural characteristics based on general bacterial acyl carrier protein biology.
Bacterial acyl carrier proteins typically:
Are small, acidic proteins (approximately 8-10 kDa)
Contain a conserved serine residue that becomes post-translationally modified with a 4'-phosphopantetheine prosthetic group
Possess a four-helix bundle structure with the modified serine positioned in a flexible loop region
The structural conservation of acpP across bacterial species suggests that D. acidovorans acpP likely maintains these core features, though species-specific variations may exist that could influence its interaction with other enzymes in the fatty acid synthase complex or alternative metabolic pathways specific to D. acidovorans.
For researchers seeking to express recombinant D. acidovorans acpP, several expression systems may be considered:
E. coli-based expression systems:
BL21(DE3) strains are typically preferred for their reduced protease activity
Consider using pET vector systems with T7 promoters for high-yield expression
Fusion tags such as His6, GST, or MBP can facilitate purification and may enhance solubility
Optimization considerations:
Lower temperatures (16-25°C) during induction may improve protein folding
IPTG concentration optimization (typically 0.1-1.0 mM) is recommended
Testing multiple growth media (LB, TB, or defined media) can impact yield and quality
Consider codon optimization if expression levels are low
A robust purification strategy for D. acidovorans acpP would typically involve:
Initial capture: Affinity chromatography
His-tag purification using Ni-NTA resin (if His-tagged construct)
GST-affinity chromatography (if GST-fusion is used)
Intermediate purification:
Ion exchange chromatography (likely cation exchange given acpP's acidic nature)
Optional tag cleavage step using appropriate protease (TEV, thrombin, etc.)
Polishing step:
Size exclusion chromatography to achieve high purity and remove aggregates
Buffer optimization to ensure stability (typically pH 7-8 with reducing agents)
Quality control assessments:
SDS-PAGE for purity evaluation (>95% purity target)
Mass spectrometry to confirm protein identity and integrity
Circular dichroism to assess secondary structure
Activity assays to confirm functionality (phosphopantetheinylation capacity)
Verification of 4'-phosphopantetheine attachment to the acpP is crucial for functional studies. Recommended methodologies include:
Mass spectrometry approaches:
MALDI-TOF MS to detect the mass shift (~340 Da) between apo- and holo-forms
LC-MS/MS analysis following tryptic digestion to identify the modified peptide
Top-down proteomics for intact protein analysis
Biochemical verification:
Conformational gel shift assays (apo- vs. holo-forms often migrate differently)
Phosphopantetheinyl transferase (PPTase) in vitro modification assays
Radioactive labeling using [³H]-β-alanine or [¹⁴C]-pantothenic acid incorporation
| Method | Sensitivity | Resolution | Advantages | Limitations |
|---|---|---|---|---|
| MALDI-TOF MS | High | Medium | Rapid analysis, minimal sample | Cannot distinguish modification sites |
| LC-MS/MS | Very High | High | Site-specific identification | More complex sample preparation |
| Gel shift assay | Medium | Low | Simple, accessible equipment | Qualitative rather than quantitative |
| PPTase assay | High | Medium | Functional verification | Requires active PPTase enzyme |
To investigate the interactions between D. acidovorans acpP and other fatty acid synthesis enzymes, researchers can employ:
In vitro approaches:
Pull-down assays using tagged acpP as bait
Surface plasmon resonance (SPR) for real-time binding kinetics
Isothermal titration calorimetry (ITC) for thermodynamic parameters
Crosslinking studies followed by mass spectrometry (XL-MS)
Fluorescence resonance energy transfer (FRET) using fluorescently labeled proteins
In vivo approaches:
Bacterial two-hybrid systems
Co-immunoprecipitation followed by proteomics
FRET or BRET in cellular contexts
Proximity ligation assays
Structural biology approaches:
X-ray crystallography of acpP with partner proteins
NMR studies to map interaction interfaces
Cryo-electron microscopy for larger complexes
D. acidovorans possesses remarkable metabolic capabilities that may involve acpP either directly or indirectly:
Potential role in delftibactin biosynthesis:
While the delftibactin biosynthetic pathway involves a nonribosomal peptide synthetase (NRPS) cluster (delA-delP), acyl carrier proteins can sometimes interact with or complement NRPS systems . Researchers should investigate whether:
acpP participates in loading or transferring intermediates within the delftibactin pathway
The phosphopantetheine arm of acpP could potentially interact with delftibactin intermediates
acpP expression levels correlate with delftibactin production
Connection to xenobiotic degradation:
D. acidovorans MC1 possesses specialized dioxygenases (RdpA and SdpA) for dichlorprop degradation . Researchers might explore:
Whether fatty acid metabolism (involving acpP) provides precursors or energy for xenobiotic degradation
If acpP expression is co-regulated with genes involved in biodegradation pathways
The impact of acpP knockout or overexpression on biodegradation capabilities
To determine the structure of D. acidovorans acpP, researchers should consider these approaches:
X-ray crystallography:
Requires high-purity protein (>95%)
Optimization of crystallization conditions (pH, ionic strength, temperature, precipitants)
May benefit from surface entropy reduction mutations to promote crystal packing
Consider apo- vs. holo-form crystallization attempts
NMR spectroscopy:
Particularly suitable for smaller proteins like acpP
Requires isotopic labeling (¹⁵N, ¹³C) for structural determination
Can provide dynamic information not available from crystallography
May reveal differences between apo- and holo-forms in solution
Cryo-electron microscopy:
Generally more suitable for larger complexes
Consider if studying acpP in complex with partner enzymes
Recent advances make this viable for smaller complexes
Computational approaches:
Homology modeling based on other bacterial acpP structures
Molecular dynamics simulations to study conformational dynamics
AlphaFold2 or similar AI-based structure prediction tools
Researchers facing solubility or stability issues with recombinant D. acidovorans acpP should consider:
Improving solubility:
Utilize solubility-enhancing fusion partners (MBP, SUMO, TrxA)
Optimize buffer conditions (pH, salt concentration, additives like glycerol)
Employ co-expression with chaperones (GroEL/ES, DnaK/J/GrpE)
Consider refolding from inclusion bodies if necessary
Enhancing stability:
Include reducing agents (DTT, β-mercaptoethanol) to prevent oxidation of cysteine residues
Add protease inhibitors during purification
Optimize storage conditions (temperature, buffer composition)
Test the addition of stabilizing agents (glycerol, trehalose, sucrose)
Alternative approaches:
Design truncated constructs if terminal regions contribute to instability
Introduce stabilizing mutations based on homology to stable acpP proteins
Consider co-expression with protein partners that may stabilize the structure
Ensuring proper phosphopantetheinylation of recombinant acpP can be challenging. These approaches may help:
Co-expression strategies:
Co-express acpP with a compatible phosphopantetheinyl transferase (PPTase)
Try different PPTases (Sfp, AcpS) if one is ineffective
Optimize expression conditions to improve PPTase activity
In vitro modification:
Purify apo-acpP and modify using purified PPTase
Optimize reaction conditions (Mg²⁺ concentration, pH, incubation time)
Purify holo-acpP using additional chromatography steps
Advanced approaches:
Use cell-free protein synthesis systems with PPTase supplementation
Consider chemical methods for attaching phosphopantetheine analogs
Explore enzymatic strategies using purified Coenzyme A biosynthetic enzymes
Systems biology approaches can provide valuable insights into acpP function:
Transcriptomic analyses:
RNA-Seq to identify co-expressed genes under various conditions
Compare expression patterns of acpP with fatty acid synthesis genes
Investigate expression changes during growth on different carbon sources
Examine transcriptional responses during gold ion exposure or xenobiotic degradation
Proteomic approaches:
Quantitative proteomics to measure acpP abundance across conditions
Phosphoproteomics to identify regulatory post-translational modifications
Protein-protein interaction network mapping using affinity purification-mass spectrometry
Protein turnover studies to understand acpP stability in vivo
Integration of data:
Correlation analysis between acpP expression and metabolic pathways
Pathway enrichment analysis to identify functional associations
Construction of gene regulatory networks to identify transcriptional regulators
To elucidate the physiological importance of acpP, researchers might employ:
Gene knockout/knockdown strategies:
CRISPR-Cas9 genome editing (if transformation protocols exist for D. acidovorans)
Antisense RNA expression to reduce acpP levels
Conditional knockouts using inducible promoters
Complementation and overexpression studies:
Expression of heterologous acpP proteins to assess functional conservation
Point mutations of key residues (especially the phosphopantetheine attachment site)
Domain swapping with acpP from other species
Reporter systems:
Translational fusions with fluorescent proteins to monitor expression and localization
Promoter fusions to study transcriptional regulation
Two-hybrid systems to identify interaction partners in vivo
| Approach | Advantages | Limitations | Considerations for D. acidovorans |
|---|---|---|---|
| CRISPR-Cas9 | Precise genome editing | Requires transformation protocol | May require optimization for this species |
| RNAi/Antisense RNA | Does not require complete gene deletion | Variable knockdown efficiency | Delivery method needs optimization |
| Overexpression | Easier to implement | May cause artifacts | Expression level control is important |
| Reporter fusions | Visualizes expression patterns | May affect protein function | Fusion position requires optimization |
Comparing D. acidovorans acpP with those from other metabolically versatile bacteria could provide evolutionary and functional insights:
Comparison with related environmental bacteria:
Cupriavidis metallidurans (metal resistance capabilities)
Pseudomonas putida (versatile xenobiotic degradation)
Ralstonia eutropha (polyhydroxyalkanoate production)
Functional considerations:
Sequence conservation in the phosphopantetheine attachment site
Differences in surface charge distribution that might affect protein-protein interactions
Presence of unique structural elements that could enable species-specific interactions
Conservation of residues involved in acyl-chain binding pocket
Evolutionary analysis:
Phylogenetic tree construction to understand evolutionary relationships
Assessment of selective pressure on different regions of the protein
Identification of horizontally transferred elements
Understanding how acpP functions across different metabolic contexts could reveal:
Pathway crosstalk mechanisms:
How intermediates might be shuttled between fatty acid synthesis and specialized metabolite production
Whether acpP interacts directly with enzymes involved in delftibactin biosynthesis
If acpP plays roles in providing precursors for biodegradation pathways
Regulatory insights:
Whether acpP expression is coordinated with both primary and specialized metabolism
How environmental conditions might shift acpP function between different pathways
If post-translational modifications modulate acpP's role in different metabolic contexts
Biotechnological applications:
Potential for engineering acpP to enhance production of valuable metabolites
Using acpP as a scaffold for introducing novel biosynthetic capabilities
Harnessing D. acidovorans acpP characteristics for heterologous expression systems
Several cutting-edge approaches could provide new insights:
Single-molecule techniques:
Single-molecule FRET to study conformational dynamics
Force spectroscopy to examine protein-protein interaction strengths
Super-resolution microscopy to visualize acpP localization in vivo
Synthetic biology approaches:
Minimal synthetic pathways incorporating acpP
Biosensors based on acpP interactions
Cell-free systems to reconstitute acpP-dependent pathways
Advanced computational methods:
Molecular dynamics simulations with enhanced sampling
Machine learning approaches to predict interaction partners
Systems biology models integrating acpP into metabolic networks
Knowledge of D. acidovorans acpP could lead to applications in:
Enhanced bioremediation:
Engineering acpP to improve integration with xenobiotic degradation pathways
Optimizing fatty acid metabolism to support higher degradation rates
Creating biosensors for environmental pollutants based on acpP interactions
Biomaterial production:
Enhancing gold nanoparticle formation by modifying acpP-related pathways
Engineering hybrid systems combining acpP with delftibactin production
Developing novel biomaterials by exploiting D. acidovorans metabolic capabilities
Biocatalysis applications:
Using acpP as a scaffold for designer enzymatic reactions
Developing bioconversion processes for challenging transformations
Creating chimeric proteins with acpP domains for novel activities
These research directions could significantly expand our understanding of bacterial metabolism while creating new biotechnological tools for environmental and industrial applications.